CKD Bio Corp. (KRX: 063160)
South Korea
· Delayed Price · Currency is KRW 29,950
+100 (0.34%)
Oct 11, 2024, 3:30 PM KST
CKD Bio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 10, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Market Capitalization | 159,367 | 130,566 | 229,313 | 438,328 | 158,885 | 106,437 | Upgrade
|
| Market Cap Growth | 6.51% | -43.06% | -47.68% | 175.88% | 49.28% | 68.02% | Upgrade
|
| Enterprise Value | 306,147 | 251,285 | 333,496 | 515,471 | 171,618 | 114,125 | Upgrade
|
| Last Close Price | 29050.00 | 23800.00 | 41800.00 | 79707.00 | 29348.99 | 19529.89 | Upgrade
|
| PE Ratio | - | -7.82 | -34.87 | 69.47 | 12.89 | 13.22 | Upgrade
|
| PS Ratio | 1.00 | 0.84 | 1.61 | 3.52 | 1.16 | 0.85 | Upgrade
|
| PB Ratio | 1.21 | 0.88 | 1.42 | 2.60 | 1.00 | 0.72 | Upgrade
|
| P/FCF Ratio | -5.50 | -13.88 | -8.70 | -7.71 | -5.24 | -123.66 | Upgrade
|
| P/OCF Ratio | -7.57 | -40.74 | -38.98 | 90.86 | 9.35 | 6.85 | Upgrade
|
| EV/Sales Ratio | 1.91 | 1.61 | 2.34 | 4.14 | 1.25 | 0.92 | Upgrade
|
| EV/EBITDA Ratio | -35.35 | 80.34 | 60.07 | 25.98 | 6.81 | 7.15 | Upgrade
|
| EV/EBIT Ratio | -10.44 | -16.97 | -29.17 | 67.76 | 11.13 | 16.28 | Upgrade
|
| EV/FCF Ratio | -13.41 | -26.72 | -12.65 | -9.07 | -5.66 | -132.59 | Upgrade
|
| Debt / Equity Ratio | 1.21 | 0.94 | 0.68 | 0.47 | 0.18 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | - | 44.41 | 19.70 | 4.02 | 1.13 | 0.31 | Upgrade
|
| Debt / FCF Ratio | -6.97 | -14.77 | -4.15 | -1.40 | -0.94 | -5.71 | Upgrade
|
| Asset Turnover | 0.51 | 0.51 | 0.49 | 0.48 | 0.66 | - | Upgrade
|
| Inventory Turnover | 2.04 | 1.87 | 1.99 | 2.14 | 3.38 | - | Upgrade
|
| Quick Ratio | 0.65 | 0.49 | 0.75 | 0.58 | 1.06 | 2.02 | Upgrade
|
| Current Ratio | 1.56 | 1.51 | 2.35 | 1.92 | 1.78 | 3.31 | Upgrade
|
| Return on Equity (ROE) | -16.26% | -10.80% | -3.98% | 3.79% | 8.01% | - | Upgrade
|
| Return on Assets (ROA) | -4.96% | -3.03% | -2.46% | 1.84% | 4.61% | - | Upgrade
|
| Return on Capital (ROIC) | -5.54% | -3.32% | -2.75% | 2.18% | 5.68% | - | Upgrade
|
| Earnings Yield | -14.51% | -12.79% | -2.87% | 1.42% | 7.72% | 7.48% | Upgrade
|
| FCF Yield | -14.33% | -7.20% | -11.50% | -12.97% | -19.09% | -0.81% | Upgrade
|
| Dividend Yield | 0.00% | - | 0.24% | 0.25% | 0.65% | 0.98% | Upgrade
|
| Payout Ratio | 0.00% | - | - | 16.53% | 8.36% | 25.79% | Upgrade
|
| Buyback Yield / Dilution | 0.02% | - | -1.40% | -0.45% | 0.00% | 0.03% | Upgrade
|
| Total Shareholder Return | 0.02% | - | -1.16% | -0.20% | 0.65% | 1.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.